IL6 and relapsing-remitting multiple sclerosis: Finally, reduced disease severity after elimination of B cells secreting IL-6 in two EAE models as well as in patients with relapsing remitting MS [64,65] supports a destructive role for IL-6 during CNS autoimmunity.